Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
SCB-002 by SCBio for Pancreatic Cancer: Likelihood of Approval
SCB-002 is under clinical development by SCBio and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase I...